DK166584B1 - Substituerede 4-benzyl-1h-imidazoler, fremgangsmaade til deres fremstilling samt farmaceutiske praeparater indeholdende dem - Google Patents

Substituerede 4-benzyl-1h-imidazoler, fremgangsmaade til deres fremstilling samt farmaceutiske praeparater indeholdende dem Download PDF

Info

Publication number
DK166584B1
DK166584B1 DK572987A DK572987A DK166584B1 DK 166584 B1 DK166584 B1 DK 166584B1 DK 572987 A DK572987 A DK 572987A DK 572987 A DK572987 A DK 572987A DK 166584 B1 DK166584 B1 DK 166584B1
Authority
DK
Denmark
Prior art keywords
imidazole
methyl
benzodioxin
methanol
dimethyl
Prior art date
Application number
DK572987A
Other languages
Danish (da)
English (en)
Other versions
DK572987D0 (da
DK572987A (da
Inventor
Eric Cossement
Jean-Pierre Geerts
Jean Gobert
Philippe Michel
Original Assignee
Ucb Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Sa filed Critical Ucb Sa
Publication of DK572987D0 publication Critical patent/DK572987D0/da
Publication of DK572987A publication Critical patent/DK572987A/da
Application granted granted Critical
Publication of DK166584B1 publication Critical patent/DK166584B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/58—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Resins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)
DK572987A 1986-11-04 1987-11-02 Substituerede 4-benzyl-1h-imidazoler, fremgangsmaade til deres fremstilling samt farmaceutiske praeparater indeholdende dem DK166584B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868626287A GB8626287D0 (en) 1986-11-04 1986-11-04 Substituted 1h-imidazoles
GB8626287 1986-11-04

Publications (3)

Publication Number Publication Date
DK572987D0 DK572987D0 (da) 1987-11-02
DK572987A DK572987A (da) 1988-05-05
DK166584B1 true DK166584B1 (da) 1993-06-14

Family

ID=10606751

Family Applications (1)

Application Number Title Priority Date Filing Date
DK572987A DK166584B1 (da) 1986-11-04 1987-11-02 Substituerede 4-benzyl-1h-imidazoler, fremgangsmaade til deres fremstilling samt farmaceutiske praeparater indeholdende dem

Country Status (24)

Country Link
US (1) US4814343A (ja)
EP (1) EP0269599B1 (ja)
JP (1) JP2632877B2 (ja)
KR (1) KR910003116B1 (ja)
AT (1) ATE98640T1 (ja)
AU (1) AU592733B2 (ja)
CA (1) CA1301174C (ja)
CY (1) CY1845A (ja)
DE (1) DE3788507T2 (ja)
DK (1) DK166584B1 (ja)
ES (1) ES2060608T3 (ja)
FI (1) FI91858C (ja)
GB (1) GB8626287D0 (ja)
HK (1) HK78895A (ja)
HU (1) HU206684B (ja)
IE (1) IE61901B1 (ja)
IL (1) IL84322A (ja)
MY (1) MY102578A (ja)
NO (1) NO169960C (ja)
NZ (1) NZ222382A (ja)
PL (3) PL155119B1 (ja)
PT (1) PT86040B (ja)
SU (4) SU1662349A3 (ja)
ZA (1) ZA878170B (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0249772A (ja) * 1988-04-07 1990-02-20 Glaxo Group Ltd イミダゾール誘導体
GB8810067D0 (en) * 1988-04-28 1988-06-02 Ucb Sa Substituted 1-(1h-imidazol-4-yl)alkyl-benzamides
JPH04252867A (ja) * 1991-01-25 1992-09-08 Nissan Motor Co Ltd 内燃機関の燃料供給装置
GB9310965D0 (en) * 1993-05-27 1993-07-14 Ucb Sa 2-hydroxy-3-(1h-imidazol-4-yl)alkyl)benzenecarboximidamides
HUT74386A (en) * 1993-11-15 1996-12-30 Schering Corp Phenyl-alkyl imidazoles as h3-receptor antagonists and pharmaceutical compositions containing them
GB9425211D0 (en) * 1994-12-14 1995-02-15 Ucb Sa Substituted 1H-imidazoles
GB9521680D0 (en) * 1995-10-23 1996-01-03 Orion Yhtymo Oy New use of imidazole derivatives
US7868020B2 (en) * 2007-01-12 2011-01-11 Allergan, Inc. Quinolynylmethylimidizoles as therapeutic agents
US8119807B2 (en) * 2007-01-12 2012-02-21 Allergan, Inc. Quinolynylmethylimidizoles as therapeutic agents
WO2008086131A1 (en) * 2007-01-12 2008-07-17 Allergan, Inc. Naphthylmethylimidizoles as therapeutic agents

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US29761A (en) * 1860-08-28 Improvements in telegraphic apparatus
US4062967A (en) 1974-02-07 1977-12-13 Smith Kline & French Laboratories Limited Bis-guanidino-alkane compounds
AU518569B2 (en) * 1979-08-07 1981-10-08 Farmos-Yhtyma Oy 4-benzyl- and 4-benzoyl imidazole derivatives
GB2092569B (en) * 1981-02-05 1984-09-19 Farmos Oy Substituted imidazole derivatives and their preparation and use
GB2101114B (en) * 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use
DE4224020A1 (de) * 1992-07-22 1994-01-27 Deutsche Aerospace Verfahren zur Auslösung der Zündung eines Gefechtskopfes und Anordnung zum Durchführen des Verfahrens

Also Published As

Publication number Publication date
ATE98640T1 (de) 1994-01-15
CY1845A (en) 1996-03-08
NO874572L (no) 1988-05-05
FI874789A0 (fi) 1987-10-30
MY102578A (en) 1992-07-31
NO169960C (no) 1992-08-26
JP2632877B2 (ja) 1997-07-23
PT86040A (pt) 1987-11-01
AU592733B2 (en) 1990-01-18
HU206684B (en) 1992-12-28
PT86040B (pt) 1990-07-31
PL268558A1 (en) 1988-09-01
IE872963L (en) 1988-05-04
EP0269599B1 (fr) 1993-12-15
HK78895A (en) 1995-05-26
PL156482B1 (pl) 1992-03-31
NO169960B (no) 1992-05-18
AU8059387A (en) 1988-05-05
KR880006205A (ko) 1988-07-22
PL155119B1 (en) 1991-10-31
FI91858C (fi) 1994-08-25
ES2060608T3 (es) 1994-12-01
DE3788507T2 (de) 1994-05-19
IL84322A0 (en) 1988-03-31
DK572987D0 (da) 1987-11-02
EP0269599A3 (en) 1990-03-14
KR910003116B1 (ko) 1991-05-18
ZA878170B (en) 1989-07-26
CA1301174C (en) 1992-05-19
SU1662349A3 (ru) 1991-07-07
IE61901B1 (en) 1994-11-30
GB8626287D0 (en) 1986-12-03
US4814343A (en) 1989-03-21
HUT56547A (en) 1991-09-30
DK572987A (da) 1988-05-05
NZ222382A (en) 1991-07-26
SU1635899A3 (ru) 1991-03-15
PL156483B1 (en) 1992-03-31
JPS63132876A (ja) 1988-06-04
SU1628857A3 (ru) 1991-02-15
SU1710558A1 (ru) 1992-02-07
EP0269599A2 (fr) 1988-06-01
FI874789A (fi) 1988-05-05
DE3788507D1 (de) 1994-01-27
FI91858B (fi) 1994-05-13
IL84322A (en) 1991-08-16
NO874572D0 (no) 1987-11-03

Similar Documents

Publication Publication Date Title
US4007196A (en) 4-Phenylpiperidine compounds
IE52118B1 (en) Imidazole derivatives,preparation thereof and pharmaceutical preparations containing them
DK151800B (da) Analogifremgangsmaade til fremstilling af et 2-phenylenmorpholinderivat, herunder dettes optiske isomere, eller et farmaceutisk acceptabelt syreadditionssalt deraf
DK166584B1 (da) Substituerede 4-benzyl-1h-imidazoler, fremgangsmaade til deres fremstilling samt farmaceutiske praeparater indeholdende dem
US5328917A (en) Piperidine compounds for treating anoxia, cerebral ischemia migraine or epilepsy
NO146359B (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive cyproheptadinderivater
EP0009800A2 (en) 4-Phenyl-1,3-benzodiazepines, method for their preparation, pharmaceutical compositions containing them, and the compounds for use as medicaments
US4109088A (en) 2-(indenyloxymethyl) morpholine derivatives
DK158944B (da) Analogifremgangsmaade til fremstilling af substituerede methylimidazolforbindelser
US5118687A (en) 1-oxa-2-oxo-8-azaspiro(4,5)decane derivatives, pharmaceutical compositions containing them and process for preparing same
CA1209142A (fr) Procede d'obtention de nouvelles cyanoguanidines et des compositions pharmaceutiques en renfermant
KR830001838B1 (ko) 페닐-퀴놀리지딘의 제조방법
FR2605008A1 (fr) Derives d'imidazo (4,5-b)pyridinone-2, leur preparation et leur application en therapeutique
DK162092B (da) Basisk substituerede 3-phenyl-quinolin-2-on-derivater, deres fremstilling og anvendelse samt laegemiddel indeholdende disse derivater
NZ192744A (en) 4-amino-2-piperidinoquinazoline derivatives and pharmaceutical compositions containing them
US4318909A (en) Benzoxazocines
IE67059B1 (en) A process for the preparation of a 1,4-dihydropyridine derivative namely (-)-2-{[2-(aminoethoxy)ethoxy]methyl}-4-(2,3-dichlorophenyl)-3-ethoxy-carbonyl-5-methoxycarbonyl-6-methyl-1,4-dihydropyridine and its salts
US4626522A (en) Benzoxazocines intermediates
FR2640975A1 (ja)
CA2023019A1 (en) 1-oxa-2-oxo-8-azaspiro/4,5/decane derivatives, pharmaceutical compositions containing them and process for preparing the same
NO127969B (ja)
GB2041373A (en) Quinazoline antihypertensives
NO154194B (no) Analogifremgangsm¨te til fremstilling av terapeutisk aktiv e diaryloktahydropyrazinopyrimidoner
NO146281B (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 3-amino-4-karbamyl-pyrrolderivater